CATABOLISM AND EXCRETION OF CHOLESTEROL AND BILE ACIDS

胆固醇和胆汁酸的分解代谢和排泄

基本信息

  • 批准号:
    6198959
  • 负责人:
  • 金额:
    $ 29.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-15 至 2003-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: The goal of this proposal is to determine how two key pathways of bile acid biosynthesis are regulated by dietary cholesterol and to determine the mechanisms regulating the apical Na+ -dependent bile-acid transport protein (ASBP) in the ileum. This proposal combines approaches and animal models that have not been combined before to test some basic hypotheses regarding the metabolism and excretion of cholesterol. The proposal has the following goals: 1). To test the hypothesis that the two pathways of bile acid synthesis, the cholesterol 7alpha-hydroxylase pathway and the sterol 27-hydroxylase pathway, are regulated independently, and patterns of regulation depend on cholesterol responsiveness. This will be tested by three different approaches and will take advantage of a unique hypercholesterolemia-resistant rabbit developed at the University of Texas. The applicant proposes a longitudinal study using deuterated 7-alpha hydroxycholesterol and 27-hydroxylated cholesterol as bile acid precursors. These studies will precisely measure rates of bile acid synthesis in vivo as animals are fed a hypercholesterolemic and then a hypocholesterolemic diet. The second component of this specific aim will assess rates of bile acid synthesis by the two pathways in an animal with a total bile acid diversion. The third component of this specific aim is directed a elucidating the mechanism through which these two pathways are regulated. The applicant will examine both steady-state rates of mRNA and use a novel transcription assay to assess how altered rates of enzyme biosynthesis is achieved in vivo. 2). To test the hypothesis that expression of ASBP is regulated by both transcriptional and post-transcriptional mechanisms. This will be tested both in normal and in the hypercholesterolemia-resistant rabbits and the applicant will examine levels in the activity, mRNA, and transcription of the transporter and determine if changes in mRNA are reflected in levels of ASBP protein and localization. In addition, the applicant will determine the functional consequences of ASBP allele found in the hypercholesterolemic rabbit. These studies will make a significant contribution to the understanding of the only routes by which significant cholesterol is removed from the body. In this respect the applicant anticipates that the results will impact upon the treatment of cardiovascular diseases well as having significance for fundamental biological questions of the control of cholesterol homeostasis.
描述:本提案的目标是确定如何两个关键途径

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S LOOSE其他文献

DAVID S LOOSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S LOOSE', 18)}}的其他基金

Biomarkers Core
生物标志物核心
  • 批准号:
    7962041
  • 财政年份:
    2010
  • 资助金额:
    $ 29.32万
  • 项目类别:
CATABOLISM AND EXCRETION OF CHOLESTEROL AND BILE ACIDS
胆固醇和胆汁酸的分解代谢和排泄
  • 批准号:
    6381509
  • 财政年份:
    2000
  • 资助金额:
    $ 29.32万
  • 项目类别:
CATABOLISM AND EXCRETION OF CHOLESTEROL AND BILE ACIDS
胆固醇和胆汁酸的分解代谢和排泄
  • 批准号:
    6524239
  • 财政年份:
    2000
  • 资助金额:
    $ 29.32万
  • 项目类别:
PHOSPHOENOLPYYRUVATE CARBOXYKINASE IN ADIPOSE TISSUE
脂肪组织中的磷酸酚丙酮酸羧激酶
  • 批准号:
    3462916
  • 财政年份:
    1987
  • 资助金额:
    $ 29.32万
  • 项目类别:
PHOSPHOENOLPYYRUVATE CARBOXYKINASE IN ADIPOSE TISSUE
脂肪组织中的磷酸酚丙酮酸羧激酶
  • 批准号:
    3462918
  • 财政年份:
    1987
  • 资助金额:
    $ 29.32万
  • 项目类别:
PHOSPHOENOLPYYRUVATE CARBOXYKINASE IN ADIPOSE TISSUE
脂肪组织中的磷酸酚丙酮酸羧激酶
  • 批准号:
    3462917
  • 财政年份:
    1987
  • 资助金额:
    $ 29.32万
  • 项目类别:
PHOSPHOENOLPYYRUVATE CARBOXYKINASE IN ADIPOSE TISSUE
脂肪组织中的磷酸酚丙酮酸羧激酶
  • 批准号:
    3462914
  • 财政年份:
    1987
  • 资助金额:
    $ 29.32万
  • 项目类别:
PHOSPHOENOLPYYRUVATE CARBOXYKINASE IN ADIPOSE TISSUE
脂肪组织中的磷酸酚丙酮酸羧激酶
  • 批准号:
    3462915
  • 财政年份:
    1987
  • 资助金额:
    $ 29.32万
  • 项目类别:
Biomarkers Core
生物标志物核心
  • 批准号:
    9763462
  • 财政年份:
  • 资助金额:
    $ 29.32万
  • 项目类别:
Biomarkers Core
生物标志物核心
  • 批准号:
    9338142
  • 财政年份:
  • 资助金额:
    $ 29.32万
  • 项目类别:

相似国自然基金

PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
  • 批准号:
    81302714
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of cholesterol biosynthesis in CAF for tumorigenesis
CAF 中胆固醇生物合成对肿瘤发生的作用
  • 批准号:
    23K14585
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Reducing the production of toxic Abeta peptides in Alzheimer's disease by mutating the APP cholesterol-binding site: a new therapeutic strategy?
通过突变 APP 胆固醇结合位点来减少阿尔茨海默病中有毒 Abeta 肽的产生:一种新的治疗策略?
  • 批准号:
    MR/Y013859/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
    Research Grant
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
  • 批准号:
    10733720
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
  • 批准号:
    10585773
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
Cholesterol homeostasis in the vertebrate retina
脊椎动物视网膜中的胆固醇稳态
  • 批准号:
    10580969
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
  • 批准号:
    10678459
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
NASH 中胆固醇稳态与炎症消退之间的干扰串扰
  • 批准号:
    10568478
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
Understanding of cholesterol transporter mechanisms via HS-AFM and computational modeling
通过 HS-AFM 和计算模型了解胆固醇转运机制
  • 批准号:
    22KF0153
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Healthy Heart Remnant Cholesterol Tackles Diabetes in Youth
健康的心脏残余胆固醇可治疗青少年糖尿病
  • 批准号:
    499350
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
    Salary Programs
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
  • 批准号:
    10802975
  • 财政年份:
    2023
  • 资助金额:
    $ 29.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了